PE20050175A1 - Peliculas consumibles oralmente de disolucion rapida que contienen un almidon modificado para la mejora de la resistencia al calor y a la humedad - Google Patents

Peliculas consumibles oralmente de disolucion rapida que contienen un almidon modificado para la mejora de la resistencia al calor y a la humedad

Info

Publication number
PE20050175A1
PE20050175A1 PE2004000428A PE2004000428A PE20050175A1 PE 20050175 A1 PE20050175 A1 PE 20050175A1 PE 2004000428 A PE2004000428 A PE 2004000428A PE 2004000428 A PE2004000428 A PE 2004000428A PE 20050175 A1 PE20050175 A1 PE 20050175A1
Authority
PE
Peru
Prior art keywords
modified
starches
modified starch
starch
hydrochloride
Prior art date
Application number
PE2004000428A
Other languages
English (en)
Inventor
David John Fadden
Neema Mahesh Kulkarni
Albert Frank Sorg
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of PE20050175A1 publication Critical patent/PE20050175A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/14Antitussive agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Grain Derivatives (AREA)
  • Dental Preparations (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

QUE COMPRENDE: 1)DE 1% A 90%, EN PESO, SOBRE EL PESO TOTAL DE LA PELICULA, DE UN ALMIDON MODIFICADO, SELECCIONADO DE: ALMIDON MODIFICADO MECANICAMENTE, ALMIDON MODIFICADO QUIMICAMENTE, ALMIDON MODIFICADO TERMICAMENTE Y LAS COMBINACIONES DE LOS MISMOS, TALES COMO ALMIDON DE MAIZ MODIFICADOS, ALMIDONES DE TAPIOCA MODIFICADOS, ALMIDONES DE MAIZ HIDROLIZADOS POR ACIDO, ALMIDONES DE PAPA HIDROLIZADOS POR ACIDO, ALMIDONES DE TAPIOCA HIDROXIPROPILADOS, ALMIDONES DE MAIZ HIDROXIPROPILADOS, ALMIDONES MODIFICADOS PREGELATINIZADOS, ENTRE OTROS Y COMBINACIONES DE LOS MISMOS; Y, 2)UN AGENTE FARMACEUTICAMENTE ACTIVO, TAL COMO: EDISILATO DE CARAMIFENO, MENTOL, BROMHIDRATO DE DEXTROMETORFANO, CLORHIDRATO DE CLOFEDIANOL, CLORHIDRATO DE PSEUDOEFEDRINA, CLORHIDRATO DE FENILEFERINA, FENILPROPANOLAMINA, SULFATO DE PSEUDOEFEDRINA, ENTRE OTROS Y LAS COMBINACIONES DE LOS MISMOS. LA PELICULA DESCRITA SE DISUELVE RAPIDAMENTE EN LA CAVIDAD ORAL Y SE ADHIEREN A LA MUCOSA DE LA CAVIDAD ORAL Y ADEMAS LIBERA Y POTENCIA LA RETENCION DEL AGENTE FARMACEUTICAMENTE ACTIVO
PE2004000428A 2003-05-02 2004-04-29 Peliculas consumibles oralmente de disolucion rapida que contienen un almidon modificado para la mejora de la resistencia al calor y a la humedad PE20050175A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46733903P 2003-05-02 2003-05-02

Publications (1)

Publication Number Publication Date
PE20050175A1 true PE20050175A1 (es) 2005-03-21

Family

ID=33418443

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2004000428A PE20050175A1 (es) 2003-05-02 2004-04-29 Peliculas consumibles oralmente de disolucion rapida que contienen un almidon modificado para la mejora de la resistencia al calor y a la humedad

Country Status (19)

Country Link
US (1) US20040247648A1 (es)
EP (1) EP1622595A1 (es)
JP (1) JP2006525308A (es)
CN (1) CN1784218A (es)
AR (1) AR044131A1 (es)
AU (1) AU2004233744A1 (es)
BR (1) BRPI0409463A (es)
CA (1) CA2523372A1 (es)
CL (1) CL2004000931A1 (es)
CO (1) CO5640073A2 (es)
GT (1) GT200400085A (es)
MX (1) MXPA05010422A (es)
PA (1) PA8601801A1 (es)
PE (1) PE20050175A1 (es)
RU (1) RU2005129309A (es)
TW (1) TW200503786A (es)
UY (1) UY28304A1 (es)
WO (1) WO2004096193A1 (es)
ZA (1) ZA200507205B (es)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040191302A1 (en) 2003-03-28 2004-09-30 Davidson Robert S. Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films
US20040131662A1 (en) 2003-11-12 2004-07-08 Davidson Robert S. Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films
US8999372B2 (en) * 2002-11-14 2015-04-07 Cure Pharmaceutical Corporation Methods for modulating dissolution, bioavailability, bioequivalence and drug delivery profile of thin film drug delivery systems, controlled-release thin film dosage formats, and methods for their manufacture and use
US9561182B2 (en) * 2003-08-22 2017-02-07 Cure Pharmaceutical Corporation Edible films for administration of medicaments to animals, methods for their manufacture and methods for their use for the treatment of animals
US8627828B2 (en) 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
JP4931596B2 (ja) 2003-11-07 2012-05-16 ユーエス スモークレス タバコ カンパニー リミテッド ライアビリティ カンパニー タバコ組成物
DE102004002951A1 (de) * 2004-01-21 2005-08-11 Wella Ag Verfahren zur Herstellung haarfestigender Produkte in Folienform
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
PL2486942T3 (pl) 2004-11-24 2019-05-31 Meda Pharmaceuticals Inc Kompozycje zawierające azelastynę oraz sposoby ich stosowania
US8758816B2 (en) 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
NZ588134A (en) * 2005-06-17 2010-11-26 Aft Pharmaceuticals Ltd Novel pharmaceutical for use in a method for treatment of upper respiratory mucosal congestion
DE102005033943A1 (de) * 2005-07-20 2007-02-22 Hexal Ag Nicht-ausspuckbarer, oraler, schnell-zerfallender Film für ein Neuroleptikum
US20070098746A1 (en) * 2005-11-02 2007-05-03 Nichols William M Multi-layered coating technology for taste masking
IL175338A0 (en) * 2006-05-01 2006-09-05 Biota Ltd Orally administrable films and preparation thereof
US20070293582A1 (en) * 2006-06-05 2007-12-20 Malcolm Hill Epinephrine dosing regimens comprising buccal, lingual or sublingual and injectable dosage forms
US20070293581A1 (en) * 2006-06-05 2007-12-20 Malcolm Hill Methods for Buccal, Lingual or Sublingual Dosing Regimens of Epinephrine for the Treatment of Allergic Emergencies
US20070292481A1 (en) * 2006-06-16 2007-12-20 Hoffman Andrew J Packaging of Food Products with Pullulan Films
US20080152761A1 (en) * 2006-12-20 2008-06-26 Shiji Shen Packaging of Food Products with Pullulan Films
US20070298078A1 (en) * 2006-06-27 2007-12-27 Harrison Michael D Water Soluble Article for Imparting Dietary Fiber to Bottled Water
DE102006061287A1 (de) * 2006-12-22 2008-06-26 Lts Lohmann Therapie-Systeme Ag Eßbare folienförmige Zubereitung mit Cola-Geschmack
US20090011115A1 (en) * 2007-03-13 2009-01-08 Foss Carter D Edible Pullulan Films Containing Flavoring
US20080274252A1 (en) * 2007-04-12 2008-11-06 Hoffman Andrew J Pullulan film containing sweetener
US20090004254A1 (en) * 2007-06-19 2009-01-01 Todd Maibach Film comprising active drugs
AU2008334684A1 (en) * 2007-12-11 2009-06-18 Novartis Ag Multi-zone films
US20110114657A1 (en) * 2009-11-13 2011-05-19 Nygaard Leann M Beverage container holder and edible film package assembly
JP2012031164A (ja) * 2010-07-06 2012-02-16 Teika Seiyaku Kk フィルム状製剤
AR083361A1 (es) * 2010-10-08 2013-02-21 Scherer Technologies Inc R P Forma de dosificacion de rapida disolucion de vacuna oral utilizando almidon
US20130052234A1 (en) * 2011-08-25 2013-02-28 Purebrands LLC Edible strips
CN102836144A (zh) * 2012-09-28 2012-12-26 天津市聚星康华医药科技有限公司 一种去氧肾上腺素口腔速溶膜及其制备方法
US9603935B2 (en) 2013-07-31 2017-03-28 Bluepharma Oral dispersible films
CN104530489B (zh) * 2015-02-05 2017-07-07 湖南尔康制药股份有限公司 一种速溶于水的淀粉成膜组合物
EP3061501A1 (en) 2015-02-27 2016-08-31 Rottapharm Ltd. Composition for the treatment of acne
CN104983732B (zh) * 2015-05-28 2018-05-04 华润三九医药股份有限公司 一种布洛肾素那敏片及其制备方法
EP3117825A1 (en) 2015-07-16 2017-01-18 Rottapharm S.p.A. Oral formulation comprising berberine and morus alba extract
EP3939570A1 (en) * 2016-02-18 2022-01-19 Immune Therapeutics, Inc. Naltrexone for treating or preventing autoimmune and inflammatory diseases
US11213496B2 (en) 2017-09-08 2022-01-04 Insignis Therapeutics, Inc. Methods of using dipivefrin
WO2020180608A1 (en) 2019-03-01 2020-09-10 Insignis Therapeutics, Inc. Dipivefrin orally disintegrating tablet formulations
KR102221453B1 (ko) * 2019-07-19 2021-03-02 한국프라임제약주식회사 저분자 콜라겐 펩타이드 및 천연추출복합물을 포함하는 구강점막부착형 필름 조성물 및 이를 이용하여 제조된 구강점막부착형 필름
CN117653610A (zh) * 2023-09-28 2024-03-08 海南卓科制药有限公司 一种***片及其制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1142325A (en) * 1965-05-14 1969-02-05 Higham Stanley Russell Means for administering drugs
US4197289A (en) * 1975-12-15 1980-04-08 Hoffmann-La Roche Inc. Novel dosage forms
US4562020A (en) * 1982-12-11 1985-12-31 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Process for producing self-supporting glucan film
JPS60219238A (ja) * 1984-04-14 1985-11-01 Hayashibara Biochem Lab Inc 徐崩性プルラン含有成形物とその製法
DE3630603A1 (de) * 1986-09-09 1988-03-10 Desitin Arzneimittel Gmbh Darreichungs- und dosierungsform fuer arzneimittelwirkstoffe, reagentien oder dergleichen sowie verfahren zu deren herstellung
JPH0739508B2 (ja) * 1986-11-11 1995-05-01 株式会社林原生物化学研究所 プルラン・ポリエチレングリコ−ル会合物とその製造方法並びに用途
US5047244A (en) * 1988-06-03 1991-09-10 Watson Laboratories, Inc. Mucoadhesive carrier for delivery of therapeutical agent
US5354551A (en) * 1989-10-14 1994-10-11 Desitin Arzneimittel Gmbh Oral and dental hygiene preparation
DE4018247A1 (de) * 1990-06-07 1991-12-12 Lohmann Therapie Syst Lts Herstellungsverfahren fuer schnellzerfallende folienfoermige darreichungsformen
JP3232488B2 (ja) * 1992-08-20 2001-11-26 株式会社林原生物化学研究所 プルラン高含有物とその製造方法並びに用途
US5411945A (en) * 1992-08-29 1995-05-02 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Pullulan binder and its uses
US20030211136A1 (en) * 1998-09-25 2003-11-13 Neema Kulkarni Fast dissolving orally consumable films containing a sweetener
US7067116B1 (en) * 2000-03-23 2006-06-27 Warner-Lambert Company Llc Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1
US20020131990A1 (en) * 2000-11-30 2002-09-19 Barkalow David G. Pullulan free edible film compositions and methods of making the same
US6660292B2 (en) * 2001-06-19 2003-12-09 Hf Flavoring Technology Llp Rapidly disintegrating flavored film for precooked foods
US20030118653A1 (en) * 2001-07-06 2003-06-26 Lavipharm Laboratories Inc. Quick dissolving oral mucosal drug delivery device with moisture barrier coating
US6656493B2 (en) * 2001-07-30 2003-12-02 Wm. Wrigley Jr. Company Edible film formulations containing maltodextrin
EP1463490B1 (en) * 2001-10-12 2011-12-14 MonoSolRX, LLC Glucan based film delivery systems
WO2003030883A1 (en) * 2001-10-12 2003-04-17 Kosmos Pharma Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
MXPA02011337A (es) * 2001-11-16 2003-05-26 Nat Starch Chem Invest Peliculas que contienen almidon.
US20030099691A1 (en) * 2001-11-16 2003-05-29 Susan Lydzinski Films containing starch

Also Published As

Publication number Publication date
CA2523372A1 (en) 2004-11-11
MXPA05010422A (es) 2005-11-04
TW200503786A (en) 2005-02-01
CO5640073A2 (es) 2006-05-31
BRPI0409463A (pt) 2006-05-02
EP1622595A1 (en) 2006-02-08
AU2004233744A1 (en) 2004-11-11
RU2005129309A (ru) 2006-05-10
AR044131A1 (es) 2005-08-24
CN1784218A (zh) 2006-06-07
US20040247648A1 (en) 2004-12-09
CL2004000931A1 (es) 2005-01-07
PA8601801A1 (es) 2004-11-26
UY28304A1 (es) 2004-11-30
GT200400085A (es) 2005-03-03
WO2004096193A1 (en) 2004-11-11
JP2006525308A (ja) 2006-11-09
ZA200507205B (en) 2006-11-29

Similar Documents

Publication Publication Date Title
PE20050175A1 (es) Peliculas consumibles oralmente de disolucion rapida que contienen un almidon modificado para la mejora de la resistencia al calor y a la humedad
CO6160317A2 (es) Formas de dosificacion farmaceutica no manipulables que incluyen un analgesico opioide
JP2006516032A5 (es)
UY25728A1 (es) Peliculas consumibles oralmente que se disuelve rapidamente
JP2010047612A5 (es)
PE20030399A1 (es) Formas de administracion de propiverina o sus sales farmaceuticamente aceptables con liberacion prolongada de la sustancia activa
PE20070192A1 (es) Formas de dosificacion de liberacion retardada oral altamente biodisponibles de succinato de o-desmetilvenlafaxina
DOP2006000241A (es) Composiciones farmacéuticas sólidas que contienen pregabalina
TW200514579A (en) Orally dissolving films
NO20063809L (no) Belagte minitabletter av venlaflaxin hydroklorid med forlenget virkning
PE20110010A1 (es) Formulaciones liquidas de fenilefrina
AR071850A1 (es) Gomas de mascar en forma de tableta
NO20090141L (no) Stabiliserte, farmasøytiske preparater som omfatter fesoterodin
AR067184A1 (es) Uso de 6-(3-cloro-2-fluorbencil)-1-[(2s)-1-hidroxi-3-metilbutan-2-il]-7-metoxi-4-oxo-1,4-dihidroquinolina-3-carboxilico. composicion farmaceutica
AR037490A1 (es) Composiciones farmaceuticas solidas, proceso para su preparacion, kit para el tratamiento de la obesidad y uso de dichas composiciones en la elaboracion de medicamentos
ES2916604T1 (es) Ensayos de detección de nrf2 y métodos y composiciones relacionados
AR059113A1 (es) Composicion para administracion topica
UY27549A1 (es) Composiciones farmacéuticas para el tratamiento de la diabetes mellitus de tipo ii
AR061790A1 (es) Composicion farmaceutica solida para la administracion oral, formulaciones de comprimidos de liberacion inmediata de un antagonista del receptor de trombina, y su uso en la manufactura de un medicamento
AR069572A1 (es) Formulaciones farmaceuticas de fenilefrina y composiciones para absorcion transmucosal
AR039955A1 (es) Preparados con principio activo en forma de pelicula con mejora de la estabilidad quimica, y procedimiento para su fabricacion
PE20081106A1 (es) Comprimidos pediatricos de capecitabina
RU2013102893A (ru) Инкапсуляция ингредиентов в лактозной матрице для получения активных инкапсулятов
AR061166A1 (es) Composiciones farmaceuticas para la liberacion sostenida de fenilferina
JP2022009021A5 (es)

Legal Events

Date Code Title Description
FC Refusal